Protagonist Therapeutics (PTGX) Q4 2022 Earnings

15MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.93
-0.76
-0.6
-0.43

Details

Expected EPS
-0.59
Actual EPS
-0.69
Surprise EPS
-0.1
Surprise Percent
+16.95%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.69 per share for Q4 2022.

0 Comments

Share your thoughts